s
Zhiyi Biotech Successfully Completes Phase I Clinical Trial of SK10 for the Treatment of Chemotherapy-induced Diarrhea
05-07-2024, 14:36
GUANGZHOU, China, July 5, 2024 /PRNewswire/ — Zhiyi Biotech, a clinical-stage biotech leading in discovery and development of LBPs (live biotherapeutic products), today announced positive results from a Phase 1 clinical trial in U.S. of SK10. SK10 is an innovative heat-killed Bacteroides fragilis product for Chemotherapy-induced Diarrhea (CID). This was a randomized, double-blind, placebo-controlled, sequential dose-escalation clinical […] L'articolo Zhiyi Biotech Successfully Completes Phase I Clinical Trial of SK10 for the Treatment of Chemotherapy-induced Diarrhea proviene da La Ragione.
CONTINUA A LEGGERE
14
0
0
Guarda anche
La Ragione
Ieri, 21:43
Manovra, Tajani “Extraprofitto incomprensibile, concetto extraterrestre”
La Ragione
Ieri, 19:43
Confesercenti “Tetti agli affitti per le attività di prossimità”
La Ragione
Ieri, 19:43
Scontri a Roma tra i manifestanti pro Palestina e le forze dell’ordine
La Ragione
Ieri, 18:52
Alimentazione, esperti: “Con esercizio fisico pilastri longevità sana”
La Ragione
Ieri, 18:12